AMPICILLIN SODIUM FOR INJECTION BP

auro pharma inc🇨🇦 Health Canada

Approval Id: aab38f210dacb1aa
Drug Approval Canada Name: AMPICILLIN SODIUM FOR INJECTION BP
Product Name: AMPICILLIN SODIUM FOR INJECTION BP
Status: Marketed
Status Date: 2017-10-20
Original Market Date: 2017-10-20
Din: 02462303
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous , Intramuscular
Schedule: Prescription
Ahfs: 08:12.16.08
Atc Original: J01CA01 AMPICILLIN
Atc Name: j 01 ca 01
Aig Number: 0105872002
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

AMPICILLIN (AMPICILLIN SODIUM)

250 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

aab38f210dacb1aa

Type

Standard